Argos Therapeutics to Present at the 14th Annual Needham Healthcare Conference

DURHAM, N.C., April 7, 2015 (GLOBE NEWSWIRE) -- Argos Therapeutics, Inc. (Nasdaq: ARGS), a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer using its Arcelis® technology platform, today announced that Jeff Abbey, president and chief executive officer, will present at the 14th Annual Needham Healthcare Conference on Tuesday, April 14th, 2015, at 2:20 p.m. Eastern Time. Mr. Abbey will discuss the AGS-003 clinical development program, including the pivotal ADAPT phase 3 trial, as well as the AGS-004 program. The conference will be held at The Westin New York Grand Central Hotel in New York, NY.

A live audio webcast of the presentation can be accessed via the Investors section of the Company's website at www.argostherapeutics.com. Please log in approximately 5-10 minutes before the event to ensure a timely connection. A replay of the webcast will be available for 14 days following the presentation.

About Argos Therapeutics

Argos Therapeutics is a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer using its Arcelis® technology platform. Argos' most advanced product candidate, AGS-003, is being evaluated in the pivotal ADAPT phase 3 clinical trial for the treatment of metastatic renal cell carcinoma (mRCC). The Company is also developing a separate Arcelis®-based product candidate, AGS-004, for the treatment of HIV, currently being evaluated in a phase 2 clinical trial in combination with a latency reversing drug for HIV eradication in adult patients. For more information about Argos Therapeutics, visit www.argostherapeutics.com.

CONTACT: Media:
         Adam Daley
         Berry & Company Public Relations
         [email protected]
         (212) 253-8881

         Investors:
         Nancy Yu
         Burns McClellan
         [email protected]
         (212) 213-0006

You May Also Be Interested In

• Needham Starts Wealthfront Corporation (WLTH) at Buy
• Ondo Finance News Today: Real-World Asset Tokens Heat Up as Remittix Introduces the BINANCE500 Promo
• Setli Announces Shared Rental Management Platform for Hosts, Landlords, Tenants and Housemates